Medical Economics September 11, 2023
Jeffrey Bendix

Legislation also provides more funding for community health centers and diabetes research

A bipartisan bill designed to increase health care price transparency and lower costs for prescription drugs and health care services was introduced September 8 by the chairs of three House of Representatives committees with jurisdiction over health care.

Dubbed the “Lower Costs, More Transparency Act” the bill would, among other provisions, require health insurers and pharmacy benefit managers (PBMs) to disclose negotiated drug rebates and discounts, reduce out-of-pocket costs for seniors who receive medication at a hospital-owned outpatient facility or doctor’s office, and extend funding for research into diabetes treatments.

“Our bipartisan legislation…will lower costs by giving patients the health care price information they need to make the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Regulations
House Budget Vote A Step Toward Medicaid Cuts Feared By Home Care Providers
Hospitals urge lawmakers to act as Medicare telehealth policies near expiration
House Republicans pass budget blueprint that could spell Medicaid cuts
House passes budget resolution potentially impacting Medicaid
‘Massive Holes’: Nursing Homes Fear Medicaid Funding Collapse as House Passes GOP Bill

Share This Article